Form 8-K - Current report:
SEC Accession No. 0001437749-22-002942
Filing Date
2022-02-10
Accepted
2022-02-10 08:45:22
Documents
15
Period of Report
2022-02-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20220208_8k.htm   iXBRL 8-K 27376
2 EXHIBIT 99.1 ex_333368.htm EX-99.1 14284
7 ex_316856img001.jpg GRAPHIC 2561
  Complete submission text file 0001437749-22-002942.txt   181531

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20220209.xsd EX-101.SCH 3593
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20220209_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20220209_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20220209_pre.xml EX-101.PRE 11584
9 EXTRACTED XBRL INSTANCE DOCUMENT dyai20220208_8k_htm.xml XML 2573
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 22611172
SIC: 2836 Biological Products, (No Diagnostic Substances)